Skip to main content

Table 4 Comparison of clinicopathological parameters against TRF2, Bcl-xL and p53 expressions

From: Expression of TRF2 and its prognostic relevance in advanced stage cervical cancer patients

  TRF2 expression (n) OS (5 year,%) Bcl-xL expression (n) OS (5 year,%) p53 expression (n) OS (5 year,%)
Stage (n) High Low High Low High Low
 IIB (7) 5 2 2 5 3 4
n.d. 50 n.d. 80 66.7 n.d.
 IIIB-IVA (13) 8 5 9 4 6 7
50 20 11 n.d. 16.7 57.1
P log rank 0.04* 0,006* 0,01*
Histologic grade (n)       
 High grade (12) 7 5 7 5 5 7
42 20 28** 80 40** 57.1
 Low grade (8) 6 2 4 4 4 4
83 50 75 n.d. 75 n.d.
P log rank 0,14 0,01* 0,01*
  1. *Correlation is significant at the 0.05 level (2-tailed); ** 3-year survival; n: number of patients; n.d.: not determined, all censored.
\